Table 1.
Demographic characteristics of participants by NAFLD status in the U.S. National Health and Nutrition Examination Survey, 1999–2012.
Table 2.
Lab and clinical characteristics of participants by NAFLD status in the U.S. National Health and Nutrition Examination Survey, 1999–2012.
Table 3.
Predictors for advanced fibrosis in participants with NAFLD in the U.S. National Health and Nutrition Examination Survey, 1999–2012 (n = 1936).
Fig 1.
Weighted survival by NAFLD and fibrosis status based on NFS cutoffs in the National Health and Nutrition Examination Survey, 1999–2010.
NFS cutoffs for advanced fibrosis: low risk <-1.455, indeterminate risk -1.455–0.676, high risk >0.676.No NAFLD vs. NAFLD low risk: p = 0.015| No NAFLD vs. NAFLD indeterminate risk: p<0.001. No NAFLD vs. NAFLD high risk: p<0.001 |NAFLD low risk of advanced fibrosis vs NAFLD high risk of advanced fibrosis: p<0.001|
Table 4.
Risk factors for overall mortality in the U.S. National Health and Nutrition Examination Survey, 1999–2010 (n = 5,086).